TrialEuropean urology2015

Long-term Safety and Antitumor Activity in the Phase 1-2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate Cancer.

Celestia S Higano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.